Bioxcel Therapeutics

BTAI · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 5 days ago

Previous year: -$0.32

Previous year: $7.68M

-30.0%

Total Operating Expenses

$14.3M

Previous year: $15.5M

-7.6%

Cash and Equivalents

$37.3M

Previous year: $40.4M

-7.6%

Total Assets

$44.8M

Previous year: $48.9M

-8.4%

Loading...

Bioxcel Therapeutics

Unlock previous datapoints

Upgrade

Bioxcel Therapeutics

Unlock previous datapoints

Upgrade

Bioxcel Therapeutics Revenue by Segment

Revenue by Segment

IGALMI® Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$30.7M

P/E Ratio

-0.13

Sector

N/A

Industry

N/A

52-Week High

$6.74

52-Week Low

$1.16

R&D Expenses

$8.74M

SG&A Expenses

$5.38M

Total Operating Expenses

$14.3M

Net Interest Expense

$4.37M

Interest Income

$236K

Products

Get in Touch

Resources

Bioxcel Therapeutics

Bioxcel Therapeutics

Bioxcel Therapeutics

Bioxcel Therapeutics Revenue by Segment

Revenue by Segment

IGALMI® Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics